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Introduction
Angiogenesis offers enormous potential for therapeutic inter-
vention of many human disorders. Many angiogenesis-related 
factors are involved in the development of vessels during vascu-
logenesis, as well as in the induction of new vessels in response
to physiological or pathological stimuli [1]. Angiogenesis and
vasculogenesis are regulated predominantly by several different
growth factors and their associated receptor tyrosine kinases
(RTKs) [2]. Foremost among these are the vascular endothelial
growth factor (VEGF) family and its receptors which are essential
regulators of angiogenesis and vascular permeability [3]. The
central role of VEGF in angiogenesis in health and disease makes it
attractive both as a therapeutic target for anti-angiogenic drugs in
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Abstract
This study addresses an important clinical issue by identifying potential candidates of vascular endothelial growth factor (VEGF) signalling
through the Flk-1 receptor that trigger cardioprotective signals under ischaemic stress. Isolated working mouse hearts of both wild-type
(WT) and Flk-1+/– were subjected to global ischaemia (I) for 30 min. followed by 2 hrs of reperfusion (R). Flk-1+/– myocardium displayed
almost 50% reduction in Flk-1 mRNA as examined by quantitative real-time RT-PCR at the baseline level. Flk-1+/– mouse hearts displayed
reduction in left ventricular functional recovery throughout reperfusion (dp/dt 605 versus 884), after 2 hrs (P < 0.05). Coronary (1.9 versus
2.4 ml) and aortic flow (AF) (0.16 versus 1.2 ml) were reduced in Flk-1+/– after 2 hrs of reperfusion. In addition, increased infarct size (38.4%
versus 28.41%, P < 0.05) and apoptotic cardiomyocytes (495 versus 213) were observed in Flk-1+/– knockout (KO) mice. We also examined
whether ischaemic preconditioning (PC), a novel method to induce cardioprotection against ischaemia reperfusion injury, through stimulating
the VEGF signalling pathway might function in Flk-1+/– mice. We found that knocking down Flk-1 resulted in significant reduction in the cardio-
protective effect by PC compared to WT. Affymetrix gene chip analysis demonstrated down-regulation of important genes after IR and precon-
ditioning followed by ischaemia reperfusion in Flk-1+/– mice compared to WT. To get insight into the underlying molecular pathways involved
in ischaemic PC, we determined the distinct and overlapping biological processes using Ingenuity pathway analysis tool. Independent evidence
at the mRNA level supporting the Affymetrix results were validated using real-time RT-PCR for selected down-regulated genes, which are
thought to play important roles in cardioprotection after ischaemic insult. In summary, our data indicated for the first time that ischaemic PC
modifies genomic responses in heterozygous VEGFR-2/Flk-1 KO mice and abolishes its cardioprotective effect on ischaemic myocardium.
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pathological conditions, such as cancer and as a pro-angiogenic
cytokine for the treatment of ischaemic heart disease. VEGF
binds to two receptor protein tyrosine kinases, VEGFR1 (Flt-1)
and VEGFR2 (Flk-1/KDR), but most of the biological functions of
VEGF are mediated via Flk-1 [4]. We demonstrated previously
that ischaemic preconditioning (PC) induced angiogenesis in the
infarcted myocardium and resulted in up-regulation of several
transcription factors (STAT3, Pax-5, NFB, TFIID, SP1 etc). In
addition, PC reduced VEGF-mediated vascular permeability by
inhibition of c-Src in the ischaemic preconditioned group, there-
by reducing ischaemic injury in a rat myocardial infarction model
[5]. However, the mechanism by which activation of VEGFRs
elicit these cellular events is not fully understood. Recently,
attention has been directed toward studies of VEGF expression
and its  function in myocardial ischaemia/hypoxia [6–8] and
relatively  little is known regarding the mechanism of its recep-
tors, Flk-1 and Flt-1. VEGF is the only known ligand for Flk-1,
whereas Flt-1 is able to bind placental growth factor in addition
to VEGF.
Few embryological studies have demonstrated abundance of
Flk-1 in human lung tissues, whereas Flt-1 was abundant in heart,
lung and kidneys [9]. Several investigations demonstrated func-
tional difference between Flk-1 and Flt-1 in endothelial cells. In the
developing human heart, both receptors were expressed in the
myocardial capillaries, and were known to stimulate intracellular
calcium flux and VEGF stimulation. Genetically manipulated Flk-1 
knockout (KO) (homozygous) studies demonstrated early embry-
onic death due to inhibition of vasculogenesis, whereas in another
study homozygous Flt-1 disruption caused failure to assemble nor-
mal vascular channels [10]. Another important observation
showed that Flt-1 was expressed in the endothelium of both large
and small vessels, whereas Flk-1 expression was restricted only to
small vessels [11]. Recent studies demonstrated the myocardial
distribution pattern of Flk-1 and Flt-1 after rats were exposed to
whole body hypoxia followed by 24 hrs of re-oxygenation. Intense
staining was observed along the capillaries in addition to the coro-
nary arteries [7]. We also documented that intensity of staining for
both receptors increased significantly in the hypoxia/re-oxygena-
tion group compared to normoxic control. We also documented
significant improvement in myocardial function with increased cap-
illary and arteriolar density after induction of survival factors VEGF,
Bcl-2 and survivin in the chronic rat myocardial infarction model
subjected to ischaemic PC [5].
One of our recent studies indicated reduced beneficial effects
of PC in Flt-1 heterozygous KO mice compared to wild-type. This
observation may be due to down-regulation of several important
genes (obtained by DNA microarray analysis) such as oncogene 1
(Gro1), heat shock proteins, I Kappa B Kinase  (IKK), colony
stimulating factor (CSF-1) and annexin 7, suggesting the impor-
tance of VEGF /Flt-1 receptor signalling during ischaemic PC [12].
To gain a better understanding of the VEGF signalling through its
other homologous membrane-spanning high-affinity tyrosine
kinase receptor, we performed microarray analysis (Affymetrix
Gene Chip Analysis) on Flk-1+/– KO mice subjected to ischaemia
reperfusion (IR) and preconditioning followed by ischaemia reper-
fusion (PCIR) protocols. 
The results obtained from this investigation not only defined a
high number of up- and down- regulated known and unknown
genes in IR and PCIR when comparing wild-type (WT) and  KO,
but also provided functional network information. We observed
many differentially expressed genes after IR (115) and PCIR (448)
comparison between KO and WT mice. Several differentially regu-
lated genes related to cardiovascular development and function,
cell–cell signalling and interaction were identified. Therefore, the
data obtained from our Flk-1+/– study should serve as a basis for
designing future hypothesis driven signalling projects leading to a
thorough mechanistic understanding of cardioprotection through
VEGF signalling.
Experimental procedures
Experimental animals
All animals received care in compliance with the principles of lab-
oratory animal care formulated by the National Society for Medical
Research and Guide for the Care and Use of Laboratory Animals
published by the National Institutes of Health (NIH). The 
heterozygous Flk-1 KO (Strain name: B6.129-Kdrtm1Jrt/J) mice
were purchased from Jackson Laboratory (Bar Harbor, Maine,
USA). Restriction maps of the mouse Flk-1 genomic fragment, tar-
geting construct and the structure of the targeted Flk-1 allele is as
described [6].
Experimental protocol
Wild-type (WT) and Flk-1+/– KO mice (male) were randomized
into four groups. For Group I (WTIR), after 10 min. stabilization,
hearts were perfused for 40 min., followed by exposure to zero-
flow normothermic global ischaemia for 30 min. followed by 
120 min. of reperfusion (I/R). For Group II (WTPCIR), after stabi-
lization, hearts were subjected to four episodes of 4-min. global
ischaemia followed by 6-min. reperfusion before I/R. For Group
III (KOIR), hearts were perfused for 40 min. before I/R and for
Group IV (KOPCIR), hearts were subjected to the same protocol
as WTPCIR. 
Working heart preparation
Mice (25–34 g) were anaesthetized with sodium pentobarbital
(150–200 mg/kg body weight IP injection, Abbott Laboratories,
Abbott Park, IL, USA) followed by heparin (500 U/kg bw IP 
injection, Elkins-Sinn Inc., Cherry Hill, NJ, USA) injection. The heart
was excised after ensuring sufficient depth of anaesthesia and
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immediately immersed in ice-cold (4°C) perfusion buffer. The aorta
and pulmonary vein were cannulated followed by retrograde perfu-
sion in the Langendorff mode through the aortic cannula was ini-
tiated at a perfusion pressure of 60 mm Hg. The perfusion buffer
was a modified Krebs-Henseleit Bicarbonate buffer [KHB: com-
posed of (in mmol/l) 118 NaCl, 4.7 KCl, 1.2 MgSO4, 25 NaHCO3,
10 glucose and 1.7 CaCl2, gassed with 95% O2:5% CO2, filtered
through a 5-m filter to remove any particulate contaminants, pH 7.4]
which was maintained at a constant temperature of 37°C and
gassed continuously for the entire duration of the experiment [13].
After 10 min. of retrograde perfusion, the heart was switched to
antegrade perfusion mode where KHB buffer entered the cannulat-
ed left atrium at a pressure equivalent to 10 cm of water, and
passed to the left ventricle from which it was spontaneously eject-
ed through the aortic cannula. Control measurements of heart
rate, coronary flow, AF, left ventricular developed pressure (LVDP),
and its first derivative dp/dtmax were monitored, analysed and
recorded in real time using the digitized data acquisition and analy-
sis system (Micromed, Louisville, KY, USA). The stabilization pro-
cedure in WTPCIR and KOPCIR groups was followed by four short
cycles of 4 min. ischaemia and 6 min. of reperfusion in the PC
group. The ischaemia reperfusion groups (WTIR and KOIR) under-
went a time-matched perfusion. After this period, the hearts in all
groups were subjected to 30 min. ischaemia. Before the initiation
of 2 hrs reperfusion, the heart was perfused in retrograde mode to
avoid the development of high-incidence ventricular fibrillation. The
measurements of the cardiac functions were measured out at 30,
60, 90 and 120 min. of the 2 hrs reperfusion period.
Infarct size
Infarct size (n  6/group) was measured as previously described
[12, 13]. After reperfusion, hearts were immediately perfused
with 1% (w/v) triphenyltetrazolium chloride. Hearts were excised
and stored at 70°C. Sections of frozen hearts were fixed in 10%
(v/v) formalin, placed between two coverslips, and digitally
imaged with the use of an Epson scanner. To quantitate the areas
of interest in pixels, Scion Image ( 4.03 for windows) analysing
software was used.
Determination of cardiomyocyte apoptosis
Formaldehyde-fixed heart tissue sections were embedded in
paraffin, cut into transverse sections (4 m thick), and deparaf-
finized with a graded series of histoclear and ethanol solutions.
Immunohistochemical detection of apoptotic cells was carried out
using a TUNEL reaction using In Situ Cell Death Detection Kit,
Fluorescein as per the manufacturerís instructions (Roche
Diagnostics, Mannheim, Germany). The sections (n 4) were
washed 3 in phosphate buffered saline (PBS), blocked with 10%
normal goat serum in 1% bovine serum albumin (BSA) (w/v) in PBS
and incubated with anti--sarcomeric actin, Sigma) followed by
staining with TRITC-conjugated rabbit antimouse IgG (1:200 dilu-
tion; Sigma). After incubation, sections were rinsed thrice in PBS
and mounted with Vectashield mounting medium (Vector,
Burlingame, CA, USA). Observed images were captured using a
confocal laser Zeiss LSM 410 microscope. For quantitation, the
number of TUNEL-positive cardiomyocytes were counted in 100
high-power fields (HPF) [13].
Microarray analysis
This project was conducted in collaboration with the Cancer
Genomics Core facility in the Kimmel Cancer Center, Thomas
Jefferson University, Philadelphia, PA, USA. The study was per-
formed with Affymetrix Gene Chip Mouse Genome 430 2.0 array
(Affymetrix, Santa Clara, CA, USA). Mouse Genome 430 2.0 array
is a single array that contains over 45,000 probe sets representing
approximately 34,000 known mouse genes. After completion of
the protocols, left ventricular tissue was quickly frozen in liquid
nitrogen and stored at 80°C. Frozen left ventricles (n  6/group)
were homogenized and DNA-free total RNA was isolated with
RNeasy micro kit (Qiagen, Valencia, CA, USA), according to the
manufacturerís instructions. DNase-treated RNA was ethanol pre-
cipitated and quantified on a NanoDrop ND-1000 spectropho-
tometer, followed by RNA quality assessment by analysis on an
Agilent 2100 bioanalyser (Agilent, Palo Alto, CA, USA). First-
strand cDNA was synthesized using Oligo dT and Superscript II RT
(Invitrogen, Grand Island, NY, USA). Alternatively, cDNA was pre-
pared using OVATION RNA Amplification System (NuGen
Technologies, Inc., San Carlos, CA, USA). cDNA amplification
products were fragmented and chemically labelled with biotin to
generate biotinylated cDNA targets. Each Affymetrix gene chip for
mouse genome 430 2.0 were hybridized with fragmented and
biotin-labelled target (2.5 g) in 200 l of hybridization cocktail.
Target denaturation was performed at 99°C for 2 min., followed by
hybridization for 18 hrs. Arrays then were washed and stained
using Genechip Fluidic Station 450, and hybridization signals were
amplified using antibody amplification with goat IgG (Sigma-
Aldrich) and anti-streptavidin biotinylated antibody (Vector
Laboratories, Burlingame, CA, USA). Chips were scanned on a
Affymetrix Gene Chip Scanner 3000, using GeneChip Operating
Software (GCOS) version 3.0. Background correction and normal-
ization were done using Robust Multichip Average (RMA) with
Genespring V 7.3.1 software (Silicon Genetics, Redwood City, CA,
USA). Volcano plots were used to identify differentially expressed
genes using the parametric testing assuming variances are 
equal (filters based on the results of a Student’s two-sample t-test
for two groups or a one-way analysis of variance (ANOVA) for 
multiple groups) and no multiple testing correction. Two different 
comparisons were done (WTIR versus KOIR and WTPCIR 
versus KOPCIR). The differentially expressed gene list was
loaded into Ingenuity Pathway Analysis (IPA) 5.0 software
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(www.ingenuity.com) to perform biological network and 
functional analyses.
Quantitative real-time RT-PCR
Reverse transcription (RT) was performed with 1 g total RNA
isolated from left ventricular tissue (n  6/group) of WT and Flk-
1+/– heterozygous KO mice subjected to I/R with or without PC.
Real-time RT-PCR analysis was done with 10 ng of RT product
using the iCycler iQ detection system (Biorad, Hercules, CA, USA)
employing Syber Green I fluorescence employing -actin as reference
control [12, 13]. Primer sequences used for real-time RT-PCR are
given in Table S1 (Supplemental file).
Statistical analysis
The values for myocardial haemodynamic parameters, infarct
size, apoptosis and quantitative real time PCR were all expressed
as the mean 	 standard deviation (	 SD). Differences between
groups were tested for statistical significance by one-way analy-
sis of variance (ANOVA) followed by a Bonferroni correction to test
for differences between the mean values of all groups with the
Fig. 1 RT-PCR and real-time RT-
PCR analysis for Flk-1, Flt-1 and
vascular endothelial growth factor
(VEGF). (A) Relative abundance (%)
of Flk-1, Flt-1 and VEGF mRNA in
wild-type (WT) and Flk-1+/– knock-
out myocardium (n 6/group) at the
baseline level, after ischaemia/ reper-
fusion (IR) and after ischaemic pre-
conditioning (PCIR) followed by IR.
(B) Quantitative real-time RT-PCR
analysis validating RT-PCR data for
VEGF, Flt-1 and Flk-1 mRNA. *P <
0.05 compared with WT
ischaemia/reperfusion, #P < 0.05
compared with WT preconditioning,
†P < 0.05 compared with KO
ischaemia/reperfusion.
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help of statistical tool (SPSS 15.0). The results were considered
significant if P < 0.05.
Results
Characterization of Flk-1 heterozygous KO mice
Almost 50% reduction in Flk-1 mRNA was found in hearts from
heterozyogous Flk-1 KO mice (Fig. 1A and B) assessed by both RT-
PCR and real-time RT-PCR. Moreover, Flk-1 mRNA expression is
significantly inhibited in the KOPCIR compared to the WTPCIR
myocardium. As expected, expression of Flt-1 and VEGF mRNA are
not affected in Flk-1+/– mice before or after I/R (Fig. 1A and B);
however, after PC both Flt-1 and VEGF mRNA expression in KOPCIR
and WTPCIR were increased compared to I/R.
Effect of Flk-1 heterozygosity on the recovery of
ventricular function after ischaemia reperfusion 
There was no significant difference in baseline function among the
four groups. Throughout the study, the heart rate and coronary
flow were not different between the two groups (data not shown).
The functional values of each parameter, such as LVDP, dp/dtmax
and AF, were significantly decreased in all groups after 30 min. of
global ischaemia, as expected, compared to their respective base-
line values. Post-ischaemic myocardial function was disrupted in
the Flk-1+/– mice significantly as evidenced by the significant
decrease in LVDP, dp/dtmax and AF compared to wild-type control.
A significant decrease in LVDP (Fig. 2A) was observed throughout
the reperfusion period (except at 30´R). Values after 120 min. of
reperfusion for LVDP in KOIR (49.8 	 1.2) and KOPCIR (54.4 	
2.6) decreased compared to WTIR (56.8 	 1.1) and WTPCIR 
(65 	 3). A significant decrease in dp/dtmax (Fig. 2B) also was
obtained throughout the reperfusion time after 120 min. of reper-
fusion in both KOIR (605 	 13) and KOPCIR (818 	 55) as com-
pared to the WTIR (884 	 51) and WTPCIR (1267 	 51), respec-
tively. Similarly, AF (Fig. 2C) was significantly decreased after 120
min. of reperfusion in both KOIR (0.16 	 0.1) and KOPCIR (1.3 	 0.5)
compared to WTIR (1.2 	 0.18) and WTPCIR (4.3 	 0.72).
Effect of Flk-1 inhibition on myocardial 
infarct size
Infarct size expressed as percent infarction relative to total area at
risk was noticeably increased in Flk-1+/– mouse hearts compared
to controls (Fig. 3A). Transversal cross-sections from Flk-1+/–
hearts, which underwent ischaemia reperfusion (38.4%) and
ischaemic PC (27.8%) indicated significantly larger (P < 0.05)
Fig. 2 Effects of ischaemia/reperfusion and preconditioning on left ven-
tricular function of wild-type and Flk-1+/– mice. Post-ischaemic ventric-
ular recovery of Flk-1+/– and wild-type mouse hearts (n  6/group) is
presented. The results (A) left ventricular developed pressure (LVDP),
(B) dp/dtmax and (C) aortic flow are shown in Mean 	 S.D form six ani-
mals per group. *P < 0.05 compared with WT ischaemia/reperfusion,
#P < 0.05 compared with WT preconditioning, †P < 0.05 compared with
knockout (KO) ischaemia/reperfusion. WTIR, wild-type IR; WTPCIR,
preconditioned wild-type, KOIR, Flk-1+/– knockout IR; KOPCIR, precon-
ditioned Flk1+/– knockout.
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Fig. 3 Effects of ischaemia/reperfusion and
preconditioning on infarct size and car-
diomyocyte apoptosis of wild-type and Flk-
1+/– mice. (A) Infarct size of the hearts is
expressed as a percentage of the area at
risk in mouse myocardium subjected to 30
min. of ischaemia followed by 2 hrs 
of reperfusion. Results are expressed as
means 	 SD of six hearts/group. (B and C)
TUNEL assay for apoptotic cardiomyocytes
cells after ischaemia/reperfusion and pre-
conditioning of wild-type and Flk-1+/– mice
after ischaemia. TUNEL assay for apoptotic
cells was performed as described under
Experimental procedures. Representative
photographs show immunohistochemical
staining of extended DNA. Results are
expressed as means 	 SEM of six
hearts/group. *P < 0.05 compared with
wild-type ischaemia/reperfusion group, 
#P < 0.05 compared with Flk+/–
ischaemia/reperfusion group, †P < 0.05
compared with wild-type preconditioning
group. WTIR, wild-type IR; WTPCIR, pre-
conditioned wild-type; KOIR, Flk-1+/–
knockout IR; KOPCIR, preconditioned
Flk1+/– knockout.
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infarct size compared to WTIR (28.41%) and WTPCIR (19.4%)
heart sections. 
Effect of Flk-1 inhibition on cardiomyocyte apoptosis
by TUNEL Assay
Apoptotic cardiomyocytes (Fig. 3B) were detected using TUNEL
staining in conjunction with staining for -sarcomeric actin.
Apoptotic cardiomyocytes were significantly increased in the KOIR
(495) and KOPCIR (335) groups when compared to the WTIR
(213) and WTPCIR (116) groups (Fig. 3C). Hence, heterozygosity
for Flk-1 increased cardiomyocyte cell death due to apoptosis
compared to controls. Thus, the extent of cardiac injury is much
more prominent in Flk-1+/– KO mice when subjected to ischaemia
reperfusion than controls. It is also clear that PC-mediated cardio-
protection is disrupted in the KO compared to controls. 
Gene expression changes in the Flk-1 
heterozygous and WT mice by 
Affymetrix Microarray analysis 
Microarray gene profiling was conducted with RNA isolated from
the left ventricles of wild-type and KO mice to identify genes
involved in ischaemic PC-mediated VEGF signalling. Microarray
analysis was performed on RNA isolated from each group to 
Fig. 4 Volcano plot pictures showing the differentially regulated genes in both the comparisions. (A) KOIR versus WTIR, (B) KOPCIR versus WTPCIR.
Volcano plot was used as filter to view the differentially expressed genes. A volcano plot shows the log2(Fold change) in x-axis against the –log10(P-value)
in y-axis. It shows two important measures of differential expression in one plot. Filter genes for a 1.5-fold difference and P-value cut-off of 0.1. WTIR,
wild-type IR; WTPCIR, preconditioned wild-type; KOIR, Flk-1+/– knockout IR; KOPCIR, preconditioned Flk1+/– knockout.
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identify differentially expressed genes, using the Affymetrix 430
2.0 mouse genomic array. Signals were loaded into Gene Spring
7.3.1 software and normalized using the RMA algorithm
(Supplemental Fig. S1). The differentially expressed genes were
further filtered using a Volcano plot (Fig. 4). This plot shows two
important measures of differential expression in one plot
(–log10[P-value] versus log2[Fold change]), allowing decision on
which genes are differentially expressed at a particular P-value.
The gene expression profile of mouse hearts subjected to PCIR
and IR alone in KO mice was compared to the respective PCIR and
IR groups in WT mice, that is (WTIR versus KOIR and WTPCIR
versus KOPCIR). The average expression level for each gene was
calculated from biological duplicates. Using this Volcano plot at a
value P < 0.1, showed 628 differentially expressed probe sets in
KOIR versus WTIR, (Fig. 4A) and 1394 differentially expressed
probe sets in KOPCIR versus WTPCIR (Fig. 4B). The gene list was
reduced to 448 (KOPCIR versus WT PCIR) and 115 (KOIR versus
WTIR) differential expressed genes after applying a cut off inten-
sity 100. A summary of the total number of differentially expressed
genes based on a P-value <0.1 as shown (Tables 1 and 2). With the
goal of discovering specific patterns, hierarchical clustering
(Pearson correlation) was applied to the expression profiles of
555 genes (total number of differentially regulated genes). These
data are represented by a gene tree (Fig. 5) in which genes of most
similar expression patterns are closest to one another. A gene tree
or heat map is a graphical means of comparing many genes and
samples at one time where each gene and sample is represented by
a row and column, respectively. Gene expression (Normalized
expression) levels are depicted as colour variation from red (high
expression) to blue (low expression).
A partial list of down-regulated transcripts in WTIR versus
KOIR comparison (Table 3) and in WTPCIR versus KOPCIR (Table 4)
is shown. Important genes down-regulated in the KO as compared
to WT mice include kinase insert domain receptor (KDR),
Syndecan 1 and vascular endothelial cell adhesion molecule-1
(VCAM-1) which plays an important role in cardiovascular function.
The Venn diagram in Fig. 6A compares differentially expressed
genes in-between the two different comparisons, which showed 45
common genes were differentially regulated. Further classification
of the 45 genes according to biological function (Fig. 6B) was deter-
mined from the Netaffx gene ontology tool, Affymetrix analysis
shows that 11 genes are involved in catalytic activity, 25 genes in
binding activity and five in signal transduction activity. A pie chart
shows commonly regulated functions (Netaffx gene ontology tool,
Affymetrix) for the different comparisons (Fig. 6).
Biological network and functional analysis
In order to further refine the functional properties of the genes
down-regulated, the total down-regulated genes in both compar-
isons (1156 genes) were loaded in the IPA tool for the network,
Table 1 Differentially expressed genes in KOIR mice as compared with WTIR mice at different statistical criteria using Volcano plot as a filter
Table 2 Differentially expressed genes in KOPCIR mice as compared with WTPCIR mice at different statistical criteria using Volcano plot as 
a filter 
Fold change P-values Probe 
sets
100
Cut-off
Unique genes after 100
cut-off
2 0.05 79 18 18
2 0.1 172 34 32
1.5 005 306 56 56
1.5 0.1 628 115 114
Fold change P-values Probe
sets
100 
Cut-off
Unique genes after 100
cut-off
2 0.05 195 64 62
2 0.1 419 143 138
1.5 005 646 187 180
1.5 0.1 1394 448 425
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functional and pathway analysis. IPA converts a list of genes (with
or without accompanying expression information) into a set of rel-
evant networks based on the ingenuity pathways knowledge base
(IPKB). Total down-regulated genes (1156 transcripts) in both com-
parisons were selected and used for network generation and func-
tional analysis. Affymetrix probe ID and P-value were loaded into the
IPA software. A core analysis is performed for the list of genes in
individual groups, which was followed by comparison analysis
(WTIR versus KOIR and WTPCIR versus KOPCIR). The genes were
categorized based upon molecular function in the IPA software. The
identified genes were also mapped to genetic networks in the IPA
database and ranked by score. The score reflects the probability that
a collection of genes equal to or greater than the number in a net-
work could be achieved by chance alone. A score of more than 10
was used as a cut-off for identifying gene networks. The list of net-
works generated (Table 5 and 6) and important networks related to
cardiovascular function in each comparison is given (Fig. 7A and B).
Network analysis revealed two important genetic networks related
to cardiovascular development, which is shown in Fig. 7A (WTIR
versus KOIR) and 7B (WTPCIR versus KOPCIR). Two 
Fig. 5 Hierarchic clustering of differentially expressed genes in wild-type and FLK-1+/– mice after Ischaemia reperfusion and ischaemic precondition-
ing. Data filtering by volcano plot identified 555 genes together in both the comparisons (WTIR versus KOIR and WTPCIR versus KOPCIR). Gene
expression levels are depicted as colour variation from red (high expression) to blue (low expression) The colour in each cell of the figure displays
the level of expression for each gene (row) in the myocardium of each group (mean of duplicate valve) (column). WTIR, wild-type IR; WTPCIR, pre-
conditioned wild-type; KOIR, Flk-1+/– knockout IR; KOPCIR, preconditioned Flk1+/– knockout.
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networks had a high score of 42 and 26 with 22 and 16 focus genes,
respectively. Several important genes, such as AKT, AP1, FGF1,
HIF1A, IL1, MAP3k3, MEK, P38MAPK, VEGF, Eif2s3, KDR etc, are
related in the network. Further functional and pathway classification
showed, several genes down-regulated related to organismal injury
and abnormalities, cardiovascular system development and func-
tion, free radical scavenging, cellular growth and proliferation,
skeletal and muscle disorders in both comparisons. Table 7 and 8
show the list of functions with respect to the P-value and related
number of genes in WTIR versus KOIR and WTPCIR versus KOP-
CIR comparisons.
Validation of differentially expressed genes by
realtime RT-PCR
Real-time RT-PCR analysis was performed to confirm the rela-
tive expression patterns of randomly chosen down-regulated
genes in both comparisons. The four experimental groups
(WTIR, KOIR, WTPCIR and KOPCIR) were assessed for each
transcript. This approach led to successful verification of nine
transcripts involved in VEGF-mediated cardioprotection
through Flk-1 signalling during ischaemic PC and include
VCAM, HIF-1A and mitogen-activated protein kinase kinase 7
Table 3 List of selected down-regulated genes in WTIR versus KOIR
Affy ID Gene symbol Description
1419697_at CXCL11 Chemokine (C-X-C motif) ligand 11
1437478_s_at EFHD2 EF hand domain containing 2
1423136_at FGF1 Fibroblast growth factor 1
1424877_a_at ALAD Aminolevulinate, 
-, dehydratase
1434008_at SCN4B Sodium channel, type IV, 
1417343_at FXYD6 FXYD domain-containing ion transport regulator 6
1448304_a_at RAB6 RAB6, member RAS oncogene family
1449379_at KDR Kinase insert domain protein receptor
1452445_at SLC41A2 Solute carrier family 41, member 2
1436576_at A630077B13RIK RIKEN cDNA A630077B13 gene
1424365_at 1810037I17RIK RIKEN cDNA 1810037I17 gene
1416124_at CCND2 Cyclin D2 (very important)
1439540_at MARCH2 Membrane-associated ring finger (C3HC4) 2
1451343_at VPS36 Vacuolar protein sorting 36
1450036_at SGK3 Serum/glucocorticoid-regulated kinase 3
1436959_x_at NELF Nasal embryonic LHRH factor
1452053_a_at TMEM33 Transmembrane protein 33
1459783_s_at CNO Cappuccino
1434598_at LARP5 La ribonucleoprotein domain family, member 5
1448780_at SLC12A2 Solute carrier family 12, member 2
1422464_at MRPL3 Mitochondrial ribosomal protein L3
1415943_at SDC1 Syndecan 1
1434577_at BC052040 cDNA sequence BC052040
1422492_at CPOX Coproporphyrinogen oxidase
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(Fig. 8). The mRNA levels of VCAM, HIF-1A, mitogen-activated
protein kinase kinase 7 along with other genes increased in PC
groups as compared with the IR groups in both KO and WT
mice. However, the levels were significantly decreased in KO
mice. Real time RT-PCR analysis revealed results consistent
with the microarray data, thus demonstrating the accuracy of
the array approach.
Discussion
This study explores for the first time how ischaemic PC-mediat-
ed cardioprotection modifies genomic responses significantly in
Flk-1 heterozygous receptor KO mice and disrupts PC-mediated
cardioprotection. Expression of VEGF RTKs, such as Flk-1 and
Table 4 List of selected Down-regulated genes in WTPCIR versus KOPCIR
Affy ID Gene symbol Description
1448183_a_at Hif1a Hypoxia inducible factor 1,  subunit
1416123_at Ccnd2 Cyclin D2
1449379_at Kdr Kinase insert domain protein receptor
1437284_at Fzd1 Frizzled homologue 1 (Drosophila)
1415988_at Hdlbp High-density lipoprotein (HDL) binding protein
1433972_at Camta1 Calmodulin-binding transcription activator 1
1420491_at Eif2s1 Eukaryotic translation initiation factor 2, subunit 1 
1455396_at Atp8b1 ATPase, class I, type 8B, member 1 (Atp8b1), mRNA
1428230_at Prkcn Protein kinase C, 
1459457_at Camk2d Calcium/calmodulin-dependent protein kinase II, 

1425354_a_at Aggf1 Angiogenic factor with G patch and FHA domains 1
1421821_at Ldlr Low-density lipoprotein receptor
1423144_at Pik3ca Phosphatidylinositol 3-kinase, catalytic, alpha polypeptide
1425512_at Map2k7 Mitogen-activated protein kinase kinase 7
1424681_a_at Psma5 proteasome (prosome, macropain) subunit, alpha type 5
1418453_a_at Atp1b1 ATPase, Na+/K+ transporting, beta 1 polypeptide
1430500_s_at Mtx2 Metaxin 2
1451090_a_at Eif2s3x Eukaryotic translation initiation factor 2, subunit 3, structural gene X-linked
1436003_at Vcam1 Vascular cell adhesion molecule 1
1460303_at Nr3c1 Nuclear receptor subfamily 3, group C, member 1
1430990_s_at Mrpl44 Mitochondrial ribosomal protein L44
1425993_a_at Hsp110 Heat shock protein 110
1423330_at Ensa Endosulfine 
1423456_at Bzw2 Basic leucine zipper and W2 domains 2
1417204_at Kdelr2 KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2
1433641_at Smad5 MAD homologue 5 (Drosophila)
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Flt-1 in endothelial cells, has made it difficult to document indi-
vidual contributions of each receptor to VEGF signalling. This
study shows that ischaemia/reperfusion and / or PC modifies
genomic responses in Flk-1+/–KO myocardium compared to WT,
specifically, modifying expression of genes responsible for
myocardial response to ubiquitination, angiogenesis and survival,
etc. that are obviously important for cardioprotection. In the cur-
rent study, we used genetically manipulated heterozygous Flk-1
(50% down-regulated) KO mice because homozygous KO mice
are not viable due to early embryonic death caused by inhibition
of vasculogenesis [10].
As assessed by RT-PCR and real-time RT-PCR, VEGF and Flt-1
mRNA expression in KO mice, compared to WT mice, are not
affected at the baseline level by disruption of the Flk-1 gene.
However, after PC, both VEGF and Flt-1 mRNAs are significantly
up-regulated in WTPCIR and KOPCIR compared to their respec-
tive IR groups. On the other hand, as expected Flk-1 mRNA was
down-regulated (50%) at the baseline level as well as in the
KOPCIR group. These observations indicate that disruption of
Flk-1 gene does not affect PC-mediated up-regulation of VEGF
and Flt-1 mRNA. Again, functional recovery after PC deteriorates
in Flk-1+/– compared to wild-type mice. Infarct size is also found
to be greater in the KOPCIR (27.8%) than in the WTPCIR
(19.4%) group; and therefore, PC-mediated cardioprotection is
diminished significantly even though these are heterozygous KO
mice with 50% of Flk-1 receptors still available for VEGF-medi-
ated signalling. 
In this study, we have confirmed that PC-induced VEGF sig-
nalling is disrupted by knocking down Flk-1, and is characterized
by a decrease in haemodynamics, an increase in infarct size and
apoptosis. Several high-throughput technologies have been used to
investigate the effect of ischaemic PC-mediated myocardial
changes [14, 15]; but, to our knowledge, this is the first microar-
ray study of global gene expression in Flk-1+/– mice using high-
density oligonucleotide microarrays. Left ventricular RNA samples
from six mice in each group were analysed for differential expres-
sion by hybridizing with Affymetrix 430 2.0 Mouse arrays. Our
data uncovered several pathways induced by VEGF signalling
through Flk-1 and provide a framework for comparing whole-heart
gene expression changes associated with ischaemic PC. 
Gene chip data analysis with the help of Genespring software
analysis revealed 448 genes and 115 genes differentially
expressed in WTIPCIR versus KOPCIR and WTIR and KOPCIR
comparisons which showed the involvement of several genes
related with ischaemic PC-mediated VEGF-Flk-1 signalling.
Identification of the differentially expressed genes and cluster
analysis [16] of these genes are the important initial steps, but fur-
ther analysis of these genes by IPA software for net-
works/functional analysis allowed us to look into more informa-
tive and convincing evidence of changed biological  processes due
to ischaemic PC. Pathway analysis showed several genes such as
presenelin -1, AKT, AP1, FGF1, HIF1A, IL1, MAP3k3, MEK,
P38MAPK, VEGF, Eif2s3, KDR related to WNT, FGF, PI3 kinase,
cardiac  adrenergic, VEGF and platelet-derived growth factor 
Fig. 6 A Venn diagram shows the com-
mon differentially expressed genes in
between two comparisons, (KO I/R versus
WT I/R and KOPCIR versus WT PCIR).
(B). Pie chart shows the classification of
differentially expressed genes based on
biological functions (Netaffx gene ontol-
ogy tool, Affymetrix). The number repre-
sents the genes associated with a specific
function. Note that some genes may have
multiple functions and be classified in sev-
eral categories. WTIR, wild-type IR; WTP-
CIR, preconditioned wild-type; KOIR, Flk-
1+/– knockout IR; KOPCIR, preconditioned
Flk1+/– knockout.
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signalling were down-regulated in the KO mice as compared
with the WT mice during ischaemic PC. Hence, the pathway
analysis proved that knocking down Flk-1 showed disruption of
several important signalling mechanisms related to myocardial 
angiogenesis. 
To independently validate array data, eight down-regulated
genes related to myocardial angiogenesis and cardioprotection
were selected randomly followed by qRT-PCR analysis. The genes
include syndecan-1, Na+/K+ ATPase transporting,  1 polypeptide,
phosphatidylinositol 3-kinase, catalytic,  polypeptide, protein
kinase C, mitogen-activated protein kinase kinase 7, vascular cell
adhesion molecule 1, hypoxia inducible factor-1,  subunit and
glutathione reductase (GR). 
Syndecan 1 is a cell surface proteoglycan and an integral mem-
brane protein acting as receptors for the extracellular matrix.
Syndecan 1 has been proven to modulate the WNT pathway [17],
which is important in cell signalling. Na+/K+ ATPase activity in the
myocardium plays an important role in generating the rapid
upstroke of the action potential and drives several ion exchange
and transport processes crucial for normal cellular functions [18]. 
In addition, phosphatidylinositol 3-kinase is found in the down-
regulated list, and is composed of 85 kD and 110 kD subunits. The
85 kD subunit lacks PI3-kinase activity and acts as an adaptor,
coupling the 110 kD subunit (p110) to activated protein tyrosine
kinases. Phosphatidylinositol 3-kinase, catalytic,  polypeptide
has been reported to play an important role in VEGF-mediated
angiogenesis [19]. Homozygous KO for this gene leads to embryon-
ic lethality. Hetrozygous mice were viable and fertile [20], but
showed severely blunted signalling via insulin receptor substrate
(IRS) proteins, which is a key mediator of insulin, IGF1 and leptin
action. Evidence also suggested [21] a critical role for p110 in
growth factor and metabolic signalling. Our study shows that
p110 plays an important role in several signalling pathways,
including myocardial angiogenesis.
Table 5 Selected genetic networks with high scores (>10) in WTIR versus KOIR comparison
Molecules in network Score Focus genes Top functions
Akt, Ap1, BTRC, CAMK2D, CLEC11A, CXCL1, CXCL11 (includes
EG:6373), EIF2S1, FCGR1A, FGF1, HIF1A, HOMER1, IL1, IL11, IL1R2,
Jnk, MAP3K3, Mapk, Mek, P38 MAPK, PI3K, Pkc(s), PMCH, PP2A,
PPP1R1A, PSCD3, PSCDBP, PSMC3IP, PTGFR, RTN4, SIAH1,
SLC12A7, ULBP2, Vegf, WNK1
42 22 Cardiovascular system 
development and function, 
cell-to-cell signalling and 
interaction, gene expression
Amino acids, ARHGDIG, ARHGEF11, B3GALT2, CASC3, CD38, CDC6,
CDC25C, CENPJ, COG2, COG7, CPE, GYS1 (includes EG:2997),
HNRPA1, HNRPC, hydrogen peroxide, INS1, MAGOH, MCF2L, MPO,
NXF1, PHGDH, PLK3, POLR2A, POU2F1, PPM1D, PTPRO, RBM8A,
RCN1, RHOA, RHPN2, SYTL4, THOC4, TNF, TNFAIP8
27 15 Carbohydrate metabolism, lipid metabo-
lism, molecular transport
ARFGEF1, ARHGDIG, ARHGEF11, -estradiol, CAD, CD200,
CD200R1, CDH4, CLCN3, CRSP2, CUBN, DOK1, EGF, FOXA2,
HCRTR2, IGHMBP2, LDLR, Mmp, MMP2, MYO9B, PDGFB, PKIB,
PLCE1, PSCD3, RHOA, SCARB1, SERPINA1, SETD7, SGK3,
SLC9A3R1, TAF7, TBN, TBP, TRFP, USP6NL
25 15 Lipid metabolism, molecular 
transport, small molecule 
biochemistry
AK3L1, ATR, CCNA1, CCNA2, CD9, CDC6, CDC25A, CDC25B,
CDC25C, CDK6, CHEK2, COL18A1, CPOX, E2F6, E2F1 (includes
EG:1869), EGLN1, ERCC3, FBXW11, FLI1, GTF2H1, HIF1A,MGA
(includes EG:23269), MXD4, MYCT1, NDNL2, NRN1, PRKDC, RBX1,
SREBF1, STARD4, TGFB1, TP53, USP7, ZFP161, ZNF22
24 14 Cell cycle, gene expression, 
DNA replication, recombination and
repair
AHR, CLEC11A, CYP2B6, DLG2, DLG3, DLGAP1, DNAJC11, FLNB,
FOS, GRASP, GRIN1, heparin, HLTF, IL10, MAGI2, MLLT10, MMP2,
MPG, NRP1, PCNX, POLR3A, POLR3F, PPARBP, RB1, RBBP9,
retinoic acid, SE -MA3D, SHANK2, SMARCA4, S MAR -CB1, SPTBN1,
ST6GALNAC4, TCOF1 (includes EG:6949), YY1, ZFAND5
25 15 Organismal development, 
gene expression, cancer
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Another intriguing gene on this list was Protein Kinase C.
Protein kinase D (PKD)/protein kinase C [22, 23] and two recent-
ly identified serine protein kinases termed PKD2 and PKC/PKD3,
are similar in overall structure and primary amino acid sequence
to PKD [23–25] and constitute a new protein kinase subfamily
separate from the previously identified PKCs.
Interestingly, two important genes (VCAM 1 and HIF-) were
identified as down-regulated. HIF-1 (hypoxia-inducible factor-1) is
a heterodimer consisting of HIF-1 and HIF-1 subunits. The reg-
ulation of HIF-1 activity is mainly through the HIF-1  subunit.
Translocation of HIF-1  to the nucleus and heterodimerization of
the  and  subunits demonstrates adaptive responses to
Table 6 Selected genetic networks with High scores (>10) in WTPCIR versus KOPCIR comparison
Molecules in network Score Focus genes Top functions
ADRBK2, BTRC, CCND2, Creb, DRD1, DYRK2, FCGR2B, FLI1, GRIP1,
HDC, HIF1A, HIF1AN, HLTF, IL11, Jnk, Mapk, MAPT, NCAM1, NPR3,
P38 MAPK, Pdgf, PI3K, Pkc(s), PMCH, PRKG1 (includes EG:5592),
RUNX -1, Scf, SLC6A3, SP1, TCF12, Tgf beta, TLR4, Vegf, WNT5A,
YES1
45 24 Cell-to-cell signalling and 
interaction, cellular growth and prolifer-
ation, cellular development
Akt, Ap1, APAF1, CXCL11 (includes EG: 6373), DUSP6, FLI1, FST,
Hsp90, Jnk, LDL R, Mapk, NR3C1, P38 MAPK, p70 S6k, Pdgf, PDGFC,
PEPCK, PI3K, PIK3C3, PIK3CA, PMCH, PP1/PP2A, PPARGC1A,
PPM1L, PPP1R11, PSCDBP, PSMC3IP, RASSF1, Scf, SULF1, TFDP1,
Tgf-, TLR3, TRAF3, VCAM1
40 22 Endocrine system development and func-
tion, lipid metabolism, molecular trans-
port
AMOTL1, -estradiol, BMX, CD44, CDH11, CEBPG, CXCR7, DAG1,
EIF2S3, FIGF, GBP2 (includes EG:14469), GFAP, GPC1, GPRC5A,
IFNGR2, IL6, IL15, KDR, L-carnitine, LARGE, MVP, NFKBIZ,
NRP1,PLP1,PPP5C, PRKDC, PSEN1, psychosine, RAPGEF5, SDC3,
SNX10, ST6GAL1, TNF, TNFAIP8, VEGFC
26 16 Cellular movement, cardiovascular system
development and function, organismal
development
ARCN1, ATM/ATR, BCL10, BRCA1, BRCC3, BRE, CASP9, CCND2,
CHEK2, DAG1, ELK1, EPOR, GAST, HDC, HMGN3, IL3, IL1RL1, KLF7,
MDC1, PCDH7, PLK3, PTX3, RAD50, RANBP9, RAPGEF5, RELB,
ROBO1, SRPK2, TNF, TNFAIP3, TNFAIP6, TNFAIP8, TROVE2, USP11,
ZFAND5
26 16 Cell death, cell cycle, cancer
ATR, Caspase, CDH1, CDT1, CEP55, CUL4B, ERCC1,
ETS1, FAM3C, Groucho, HAS2, HNRPA2B1, HRAS, HRASLS, IGFBP3,
IGSF4(includesEG:23705), JMJD1C, MATN4, MLLT4, NOTCH1, P8,
PAXIP1, PVR,PVRL- 3, RUNX1, SOAT1, SON, TIMP3, TLE1, TP53,
TP53BP1, TRIM44, UPP1, UTY, Zn2+
24 15 Cell death, connective tissue 
disorders, cancer
ATXN1, AURKA, CDC7, CEP55, CHGN, DBF4, DDX6 (includes
EG:1656), EP400, GAPDH (includes EG:2597), GPS2, GSR, JMJD1C,
KIAA1267, MAP4, MARK4 (includesEG:57787), MCM2, MCM4,
MCM6, MCM7, MED6, MGA (includes EG:23269), MLL, PPP1R15A
(includes EG:23645), PRNP, PVRL3, SFRS10, TBL1X, TFDP1, THPO,
TNFRSF10A (includes EG:8797), TP53, TRIM44, TXNRD1, USP7,
WDR5
24 15 DNA Replication, Recombination and
repair, cell cycle, cell death
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Fig. 7 Functionally related gene
network constructed from both
the comparisons WTIR versus
KOIR (A) and WTPCIR versus
KOPCIR (B) related with cardio-
vascular system with the help of
IPA 5.0.Nodes represent genes,
with their shape representing
the functional class of the gene
product. All the focus genes are
represented by pink and the
higher intensity red colour rep-
resent lower P-value WTIR,
wild-type IR; WTPCIR, precon-
ditioned wild-type; KOIR, Flk-1+/–
knockout IR; KOPCIR, precondi-
tioned Flk1+/– knockout.
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Table 7 Gene ontology analysis of the genes affected in WTIR versus KOIR comparison
Relevant functions P-value No. of molecules
Organismal injury and abnormalities 8.39E-4 - 4.76E-2 10 10
Cardiovascular system development and function 8.39E-4 - 4.47E-2 9 9
Free radical scavenging 7.59E-3 - 7.59E-3 1 1
Cellular growth and proliferation 7.59E-3 - 4.95E-2 23 23
Haematological system development and function 7.59E-3 - 4.95E-2 14 14
Molecular transport 7.59E-3 - 4.57E-2 12 12
Cellular development 7.59E-3 - 4.47E-2 7 7
Connective tissue development and function 7.59E-3 - 4.47E-2 6 6
Drug metabolism 7.59E-3 - 4.47E-2 6 6
Cellular movement 7.59E-3 - 4.47E-2 19 19
Cell cycle 7.59E-3 - 3.74E-2 7 7
Nucleic acid metabolism 7.59E-3 - 3.74E-2 2 2
DNA replication, recombination and repair 7.59E-3 - 3.00E-2 4 4
Metabolic disease 7.59E-3 - 3.00E-2 4 4
Cardiovascular disease 6.18E-3 - 4.47E-2 8 8
Tissue development 5.89E-4 - 4.90E-2 22 22
Skeletal and muscular system development and function 5.89E-4 - 4.47E-2 10 10
Cell death 4.89E-3 - 4.76E-2 11 11
Embryonic development 4.89E-3 - 4.47E-2 4 4
Cell-to-cell signalling and interaction 4.61E-3 - 4.47E-2 19 19
Cellular assembly and organization 3.58E-3 - 4.47E-2 21 21
Skeletal and muscular disorders 3.58E-3 - 4.47E-2 11 11
Nutritional disease 3.00E-2 - 3.74E-2 1 1
Protein trafficking 2.26E-2 - 3.00E-2 2 2
Organismal development 1.58E-3 - 4.57E-2 15 15
Vitamin and mineral metabolism 1.51E-2 - 4.57E-2 4 4
Cell signalling 1.51E-2 - 4.57E-2 19 19
Post-translational modification 1.51E-2 - 3.74E-2 4 4
Cellular function and maintenance 1.51E-2 - 2.26E-2 5 5
Gene expression 1.21E-3 - 4.91E-2 27 27
Lipid metabolism 1.17E-3 - 4.47E-2 6 6
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Table 8 Gene ontology analysis of the genes affected in WTPCIR versus KOPCIR comparison
Relevant functions P-value No of Molecules
Cellular compromise 9.02E-3 - 4.43E-2 7 7
Lipid metabolism 9.02E-3 - 4.43E-2 6 6
Organismal injury and abnormalities 9.02E-3 - 4.43E-2 6 6
Cardiovascular disease 9.02E-3 - 4.43E-2 4 4
Organismal development 9.02E-3 - 4.43E-2 4 4
Carbohydrate metabolism 9.02E-3 - 4.43E-2 3 3
Endocrine system disorders 9.02E-3 - 4.43E-2 3 3
Small molecule biochemistry 9.02E-3 - 4.43E-2 23 23
Respiratory system development and function 9.02E-3 - 4.43E-2 2 2
Molecular transport 9.02E-3 - 4.43E-2 12 12
Skeletal and muscular system development and function 9.02E-3 - 4.43E-2 11 11
Skeletal and muscular disorders 9.02E-3 - 4.38E-2 9 9
Tissue development 9.02E-3 - 4.38E-2 12 12
Organ Development 9.02E-3 - 3.56E-2 6 6
DNA replication, recombination, and repair 9.02E-3 - 3.56E-2 5 5
Cardiovascular system development and function 9.02E-3 - 2.68E-2 4 4
Cell Signalling 8.21E-3 - 4.43E-2 5 5
Cellular assembly and organization 7.08E-6 - 4.43E-2 17 17
Embryonic development 6.85E-3 - 4.43E-2 9 9
Cell death 6.85E-3 - 4.43E-2 8 8
Cellular growth and proliferation 4.49E-4 - 4.43E-2 15 15
Cell-to-cell signalling and interaction 4.49E-4 - 4.43E-2 13 13
Organismal survival 3.02E-2 - 4.11E-2 15 15
Vitamin and mineral metabolism 2.68E-2 - 4.43E-2 2 2
Amino acid metabolism 2.44E-2 - 4.43E-2 9 9
Post-translational modification 2.44E-2 - 4.43E-2 8 8
Protein trafficking 2.03E-2 - 2.03E-2 5 5
Cellular function and maintenance 1.80E-2 - 4.43E-2 6 6
Tissue morphology 1.65E-3 - 4.43E-2 16 16
Gene expression 1.18E-3 - 4.43E-2 10 10
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ischaemia [26] in the myocardium promoting angiogenesis by acti-
vating target genes such as VEGF, LDH and several other genes.
VCAM-1 is a member of the immunoglobulin superfamily of
adhesion molecules [27], and is expressed in fibroblast-like cells.
The intensity of VCAM-1 expression correlates with the degree of
inflammation. The interaction of VCAM-1 and its ligands, the inte-
grins, may play significant role in angiogenesis. Pathway analysis
also demonstrated down-regulation of GR which is a homodimeric
flavoprotein which maintains the cellular thiol redox state by catalyz-
ing the reduction of glutathione disulpide (GSSG) to glutathione. Its
activity is present in both the cytosol and mitochondria [28]. 
In conclusion, use of gene chip technology allowed us for the
first time to identify several  target genes downstream of VEGF/Flk-1
signalling in PC myocardium. Moreover, biological network and
pathway analysis revealed several other related genes indirectly
affected due to down-regulation of directly affected genes in the
KO. Finally, to our knowledge, this is the first report in VEGF recep-
tor-2 KO mice (Flk-1+/–) in which several important genes related
to cardioprotection and angiogenesis have been documented and
should help to facilitate the design of effective future therapies. 
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Fig. 8 Independent validation of down-reg-
ulated genes by real-time RT-PCR. *P <
0.05 compared with wild-type ischaemia/
reperfusion group, *P < 0.05 compared with
WT ischaemia/reperfusion, #P < 0.05 com-
pared with WT preconditioning, †P < 0.05
compared with KO ischaemia/reperfusion.
WTIR, wild-type IR; WTPCIR, precondi-
tioned wild-type; KOIR, Flk-1+/– knockout IR;
KOPCIR, preconditioned Flk1+/– knockout.
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